On 12 October, from 11-12h, CET, the ETUI is hosting a webinar on cancer risks in healthcare workers: identification of Hazardous Medicinal Products (HMPs).
In the healthcare sector, 12.7 million workers across the EU are potentially exposed to Hazardous Medicinal Products (HMPs). While these drugs are vital in the treatment of different diseases (cancers, psoriasis, etc.), they can also pose health risks to those exposed to them at work like nurses, pharmacists, cleaners, etc.
The ETUI has identified 121 HMPs commonly used in the healthcare sector which can cause cancer or reproductive disorders in professionals exposed to them on a daily basis.
As the Carcinogens, Mutagens & Reprotoxic Substances Directive (CMRD – Dir (EU) 2004/37/EC) has been recently revised to specifically cover HMPs, the ETUI list of HMPs is timely to raise awareness about these risks in the healthcare sector and help employers use the European guidelines on the safe management of HMPs to be published soon by the European Commission.
Welcome and introduction
Claes-Mikael Ståhl, Deputy general secretary, ETUC (tbc)
The ETUI list of Hazardous Medicinal Products (HMPs)
Ian Lindsley, Secretary of the European Biosafety Network
Q&A with the audience moderated by Marian Schaapman, Head of the Working conditions, health and safety unit at the ETUI
Tony Musu, senior researcher in the health and safety and working conditions of the ETUI
Working language: English
Register in advance for the webinar here. After registering, you will receive a confirmation email containing information about joining the webinar.